Therapeutic Delivery – News and Features

A pilot study identified that stress, BMI, exercise, and hormonal birth control influence COVID-19 vaccine side effects. Notably, exercise impacts side effects differently between doses.

Researchers develop a patent-pending platform technology that mimics the dual-layer structure of viruses to deliver nucleic acid (NA)-based therapies to targeted cancer cells.

Researchers developed a nanoparticle system that combines STING and TRL4 agonists with tumor-targeting agents. This method improved drug delivery and activated immune responses in pancreatic cancer mice models.

Certain mixtures of small organic molecules form interesting glasses and viscous liquids, offering promising candidates for replacing polymers in various products.

A new study suggests that Manuka honey could potentially be an alternative, natural option for breast cancer prevention and treatment.

A tiny battery designed by MIT engineers could enable the deployment of cell-sized, autonomous robots for drug delivery within in the human body, as well as other applications such as locating leaks in gas pipelines.

A new study shows that cells not classically part of the immune system trigger inflammation in celiac disease.

Researchers have reengineered Toxoplasma gondii, the 'cat parasite,' transforming it from a feared threat into a groundbreaking tool for delivering drugs directly to the brain.

Houston Methodist researchers have discovered a more accurate and timely way to deliver life-saving drug therapies to the brain, laying the groundwork for more effective treatment of brain tumors and other neurological diseases.

Researchers from Zhejiang University have uncovered the mechanistic basis behind ketamine’s rapid antidepressant effects. Published in Science, this study holds significant promise for developing more effective antidepressant treatments.